Characterisation of a mitochondrial iron transporter of the pathogen Trypanosoma brucei by Zheng, Fuli et al.
1 
Characterisation of a mitochondrial iron transporter of the pathogen Trypanosoma 1 
brucei 2 
Fuli Zheng1,3#, Claudia Colasante2#, Frank Voncken3* 3 
1Department of Preventive Medicine, School of Public Health, Fujian Medical University, 4 
Xueyuan Road, Fujian, 350122, P.R. China 5 
2Institute for Anatomy and Cell Biology, Division of Medical Cell Biology, Aulweg 123, 6 
University of Giessen, 35392 Giessen, Germany 7 
3Department of Biomedical Sciences, School of Life Sciences, University of Hull, Cottingham 8 
Road, Hull, HU6 7RX, United Kingdom 9 
# These authors contributed equally to the paper 10 
11 
Running Title: The T. brucei mitochondrial iron transporter TbMCP17 12 
*To whom correspondence should be addressed: Claudia.Colasante@anatomie.med.uni-13 
giessen.de 14 
Keywords: mitochondrial transport, iron metabolism, Trypanosoma brucei, mitochondrial 15 
carrier family-proteins 16 
17 
18 




ABSTRACT  19 
Similar to higher eukaryotes, the protist parasite T. brucei harbours several iron-containing 20 
proteins that regulate DNA and protein processing, oxidative stress defence and mitochondrial 21 
respiration. The synthesis of these proteins occurs either in the cytoplasm or within the 22 
mitochondrion. For mitochondrial iron cluster protein synthesis iron needs to be transported 23 
across the solute impermeable mitochondrial membrane. In T. brucei we previously identified 24 
24 mitochondrial carrier proteins (TbMCPs) sharing conserved structural and functional 25 
features with those from higher eukaryotes. One of these carriers (TbMCP17) displayed high 26 
similarity with the iron carriers MRS3, MRS4 from yeast and mitoferrin from mammals, 27 
insects and plants. In the present study we demonstrated that TbMCP17 functions as an iron 28 
carrier by complementation studies using MRS3/4-deficient yeast. Depletion of TbMCP17 in 29 
procyclic form T. brucei resulted in growth deficiency, increased sensitivity to iron 30 
deprivation, and lowered mitochondrial iron content. Taken together our results suggest that 31 
TbMCP17 functions as a mitochondrial iron transporter in the parasite T. brucei. 32 
  33 
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INTRODUCTION  34 
Trypanosoma brucei is a protist parasite belonging to the class of the Kinetoplastida and 35 
causing African sleeping sickness in humans and Nagana in cattle [1–3]. During its life cycle, 36 
the parasite is transferred from the insect vector, the tsetse fly, to the mammalian host thereby 37 
undergoing substantial remodelling in morphology and metabolism [4]. T. brucei replicative 38 
stages that can be cultured in vitro are the bloodstream form (BSF) found in the blood and 39 
cerebrospinal fluid of mammals, and the procyclic form (PCF) residing in the mid-gut of the 40 
tsetse fly. The BSF, which lives in a glucose rich environment, derives its energy exclusively 41 
through substrate level phosphorylation reactions during glycolysis that is partially located 42 
within specialised peroxisomes (glycosomes) [5,6]. Within the insect vector, PCF T. brucei 43 
uses glucose and the amino acid proline to generate ATP through glycolysis and mitochondrial 44 
respiration [5,7–11].  45 
As the energy metabolism, the mechanism by which iron and heme are taken up is adapted to 46 
iron availability within the hosts and differs between BSF and PCF. The BSF acquires 47 
transferrin-bound iron and heme in the form of a haptoglobin–haemoglobin complex through 48 
receptor mediated endocytosis directed to the endo-lysosomal system [12–15]. Due to the 49 
absence of transferrin in the insect gut, the PCF takes up ferrous iron by endocytosis of reduced 50 
ferric complexes [16] while heme is acquired through the membrane transporter TbHrg [15]. 51 
Once within the cytoplasm, iron and heme are redistributed to intracellular sites for the 52 
synthesis of iron-containing protein. Like higher eukaryotes, T. brucei incorporates iron into 53 
iron/sulphur clusters (Fe/S) or as non-heme and non-Fe/S iron into enzymes involved in 54 
cellular processes such as DNA synthesis, protein translation, oxidative stress defence and 55 
cytochrome respiration [12,14,17]. Iron-dependent enzymes that have been identified in T. 56 
brucei are, for example, the ribonucleotide reductase that catalyses the reduction of 57 
ribonucleotides to deoxyribonucleotides necessary for DNA synthesis [18,19], superoxide 58 
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dismutase, which catalyses the dismutation of the superoxide radical (O2·-) into hydrogen 59 
peroxide [20], alternative oxidase, which re-oxidises glycolysis derived NADH [21–23], 60 
aconitase and fumarase, both TCA cycle enzymes [24] or the cytochromes of the respiratory 61 
chain [25]. Machineries responsible for the mitochondrial and cytosolic iron–sulphur cluster 62 
protein assembly and for the mitochondrial transfer of iron to non-heme/non-FeS iron proteins 63 
have all been identified in T. brucei [12,26]. The mitochondrion is an indispensable site for 64 
the synthesis of iron-sulphur cluster proteins involved in electron transport during respiration, 65 
enzymatic catalysis, oxidative stress response and the regulation of mitochondrial iron 66 
homoeostasis [27]. For the assembly of these iron-containing proteins, iron has to cross the 67 
solute-impermeable inner mitochondrial membrane. In yeast and vertebrates iron is imported 68 
into the mitochondrion by the mitochondrial iron transporters MRS3 and 4 [28–30], and 69 
mitoferrin, respectively [31]. These transporters all belong to the mitochondrial carrier family 70 
(MCF, SLC25A), which exchange various solutes, including carboxylates, nucleotides, 71 
inorganic phosphate ornithine, carnitine, and glutamine across the mitochondrial inner 72 
membrane [32,33]. MCF proteins (MCPs) control the influx rate of metabolic intermediates 73 
into the mitochondrion, regulate the flux through metabolic processes and maintain the cellular 74 
redox and ATP homeostasis [34]. The protein structure of MCPs is conserved and consist of 75 
six transmembrane domains connected by short hydrophilic loops. Each odd numbered 76 
transmembrane domain and hydrophilic loop contains a conserved signature motif [33] and 77 
amino acid contact points, which determine the substrate specificity of the carrier subtype [35]. 78 
We previously reported that T. brucei possesses 24 MCPs (TbMCPs) containing conserved 79 
structural and sequence features of MCPs from higher eukaryotes [36–39]. Amongst these 80 
carriers we identified one with high similarity to MRS3, MRS4 and mitoferrin and named it 81 
TbMCP17 [36]. In the present study, sequence alignments and phylogenetic reconstruction 82 
revealed the close relationship of TbMCP17 to plant and mammalian iron carriers. The 83 
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functionality of TbMCP17 as an iron carrier was confirmed by complementation studies using 84 
MRS3/4-deficient yeast. We also show that in PCF, the removal of TbMCP17 caused a 85 
significant growth defect, increased the sensitivity to iron deprivation, and lowered the 86 
mitochondrial iron content. Taken together, our findings suggest that TbMCP17 functions as 87 
a mitochondrial iron transporter in the parasite T. brucei. 88 
 89 
  90 
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MATERIALS AND METHODS 91 
 92 
Phylogenetic reconstruction and sequence analysis 93 
Multiple sequence alignments were generated using ClustalO [40,41]. Phylogenetic trees were 94 
constructed using MEGA7 (Molecular Evolutionary Genetics Analysis version 7.0; [42]. 95 
Protein-Blast (blast.ncbi.nlm.nih.gov) was used to retrieve iron carrier protein sequences from 96 
trypanosomatids, plants, insects, fungi and mammals. These were then imported into MEGA7 97 
and aligned. Using the neighbour-joining (NJ) method [43], a NJ tree was drawn with bootstrap 98 
set to 1000.  99 
The GenBank (gb), EMBL (emb), NCBI (XP) and Swiss protein (sp) accession numbers for 100 
the TbMCP17 alignment and the phylogenetic reconstruction were as follows: TbMCP17, 101 
Trypanosoma brucei brucei Tb927.3.2980; Trypanosoma brucei gambiense 102 
emb_CBH09968.1; Trypanosoma congolense emb_CCC89759.1; Trypanosoma vivax 103 
emb_CCC47046.1; Trypanosoma cruzi XP_822091.1; Trypanosoma vivax gb_EKG04497.1; 104 
Trypanosoma rangeli gb_ESL10208.1; Leishmania amazonensis gb_ALP75642.1; 105 
Leishmania mexicana emb_CBZ23750.1; Leishmania major emb_CBZ12619.1; Leptomonas 106 
seymouri gb_KPI87731.1; Leishmania panamensis gb_AIO00226.1; Ustilago hordei 107 
emb_CCF54811.1; Ustilago maydis gb_KIS71149.1; Pseudozyma brasiliensis 108 
gb_EST06361.1; Rhizopus microspores emb_CEJ04189.1; Moesziomyces antarcticus 109 
gb_ETS61106.1; Drosophila willistoni gb_EDW83029.1; Bactrocera cucurbitae 110 
XP_011180944.1; Drosophila mojavensis gb_EDW14539.1; Gossypium raimondii 111 
gb_KJB83905.1; Fragaria vesca XP_004294768.1; Madurella mycetomatis gb_KOP45184.1; 112 
Phanerochaete carnosa gb_EKM49983.1; Gossypium arboreum gb_KHG15442.1; 113 
Rhizoctonia solani emb_CUA78164.1; Drosophila virilis gb_EDW59237.2; Botrytis cinerea 114 
XP_001553628.1; Sesamum indicum XP_011080718.1; Homo sapiens (MFRN1) 115 
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gb_EAW63617.1; Homo sapiens (MFRN2) gb_AAK49519.1; Saccharomyces cerevisiae 116 
(MRS3p), gb_EGA61827.1; Saccharomyces cerevisiae (MRS4p) gb_AJS43107.1; 117 
Arabidopsis thaliana gb_AAP42736.1; Zea mays (MRS3) gb_ACG42379.1; Mus musculus 118 
(MFRN1) gb_AAL23859.1; Mus musculus (MFRN2) gb_AAH25908.1; Bos taurus (MFRN1) 119 
gb_AAI03256.1; Bos taurus (MFRN2) NP_001192481.1; Lucilia cuprina gb_KNC31521.1; 120 
Drosophila busckii gb_ALC47563.1; Harpegnathos saltator gb_EFN83637.1; Acyrthosiphon 121 
pisum NP_001280444.1; Aspergillus niger XP_001390994.2.  122 
 123 
Culture and transfection of Trypanosoma brucei 124 
Procyclic form PCF449 were grown in a 27 °C incubator in MEM-PROS medium [24] 125 
supplemented with 10% heat-inactivated foetal bovine serum (Lonza), 2.5 mg/ml of heme (in 126 
100 mM NaOH) 1% of penicillin/streptomycin solution (Sigma) and 5 mM proline (Sigma).  127 
For the experiments described in this paper Trypanosoma brucei cell lines were transfected 128 
with different plasmids and clonal cell lines were selected using antibiotics according to the 129 
previously published protocol [44].  130 
 131 
Yeast functional complementation 132 
Saccharomyces cerevisiae strains used in this study were wildtype strain BY4741 (MATa 133 
his3Δ1 leu2Δ0 met15Δ0 ura3Δ0, referred to as wild type below) and mitochondrial iron carrier 134 
(MRS3/4) deficient strain GW403 (mrs3/4Δ; MATa his3-Δ1 leu2-3 leu2-112 ura3-52 trp1-135 
289 mrs3Δ::loxP mrs4Δ::loxP; referred to as ∆MRS3/4 below) [45]. Yeast strains were 136 
maintained on standard YPD medium. For clone-selection following transfection, synthetic 137 
complete (SC) medium without uracil (0.67% yeast nitrogen base without amino acids, 1.4% 138 
drop-out medium supplements without histidine, leucine, tryptophan and uracil) supplemented 139 
with 60 mg/L of leucine, 20 mg/L of tryptophan, 20 mg/L of histidine, 2% of agar and 2% of 140 
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dextrose was used. To test cell growth on different carbon sources, YPD and YPG media were 141 
used. For plate growth experiments, SC medium was supplemented with dextrose (SCD 142 
medium) or glycerol (SCG medium). To simulate iron deprived condition, 80 µM of iron 143 
chelator bathophenanthrolinedisulfonic acid (BPS, Sigma) was added to the SC medium.  144 
The complete open reading frames of TbMCP17 and S. cerevisiae MRS3 (YJL133W) were 145 
PCR-amplified using the primer combination 5’-gaGGATCCatggtttccgagggcacttccgctg-3’/5’-146 
cgAAGCTTttaccgttcctccatgaacttcttggc-3’, and 5’-gaGGATCCatggtagaaaactcgtcgagtaata-147 
3’/5’-cgCTGCAGctaatacgtcattaggaaatgttttgcacattc -3’, respectively. Restriction enzyme sites 148 
used for subsequent cloning into the yeast centromeric expression vector pCM190 (Euroscarf) 149 
are underlined and capitalised.  150 
Plasmids containing either TbMCP17 or MRS3 were transformed into the yeast strain GW403, 151 
using the lithium acetate/single-stranded carrier DNA method described by Gietz and Woods 152 
[46]. Obtained yeast clones were maintained on synthetic complete dextrose (glucose) medium 153 
without uracil in the presence of tetracycline. Heterologous protein expression in yeast was 154 
induced by tetracycline removal [47].  155 
For the growth experiments, yeast cells from an overnight starter culture were inoculated in 156 
20 ml of medium and the OD600 measured every 3 to 4 h until cells reached stationary phase. 157 
For plating experiment, yeast was spotted on agar plates at OD600 1, 0.1, 0.01 and 0.001.  158 
 159 
Over-expression of TbMCP17 160 
The open reading frame (ORF) of TbMCP17 was amplified from T. brucei 449 genomic DNA 161 
using the primer pair 5’-ggacggAAGCTTaccatggtttccgagggcacttccgctg-3’/5’- 162 
gcttgcaGGATCCccgttcctccatgaacttcttggc-3’. The restriction sites used for subsequent cloning 163 
into the pHU1 or pHU2 T. brucei expression vectors [48] are underlined and capitalised. The 164 
expression vectors generate either C-terminally (pHU1) or N-terminally (pHU2) 2×myc-165 
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tagged recombinant proteins. Comparison of the cloned TbMCP17 sequence with the sequence 166 
obtained from the genome sequence database (GeneDB) of T. brucei strain 927 revealed only 167 
a few sequence differences at the DNA level, but none in the predicted amino acid sequence. 168 
The obtained vectors were used to transfect the PCF Trypanosoma brucei strain Lister 427, 169 
stably expressing the tetracycline (tet) repressor from the plasmid pHD449 (PCF449). 170 
Hygromycin resistant clonal cell lines were isolated and analysed by western blotting after 171 
induction of tagged TbMCP17 expression using tetracycline (0.5 mg/ml). The generated cell 172 
lines are further referred to as TbMCP17-cmycti (C-terminally-tagged TbMCP17) and 173 
TbMCP17-nmycti (N-terminally-tagged TbMCP17). 174 
 175 
Immunofluorescence analysis 176 
Immunofluorescence analysis using paraformaldehyde-fixed trypanosomes was performed as 177 
previously described [36] with minor adjustments: an aliquot of culture containing 178 
approximately 1×107 cells was stained with 0.5 µM Mitotracker Red CMXRos (Sigma) for 30 179 
min. Cells were then fixed onto coverslips using freshly made 4% (w/v) paraformaldehyde in 180 
1x PBS and left to attach overnight at 4°C. For permeabilisation 0.2% (w/v) Triton X-100 was 181 
added followed by incubation with 0.5% (w/v) gelatine in 1x PBS. Afterwards, myc-primary 182 
antibody (Roche) was added to the coverslips at a dilution of 1:500 in 0.5% (w/v) gelatine in 183 
1x PBS and incubated for 60 min. Coverslips were then washed twice in 1x PBS. A 1:500 184 
dilution of the secondary antibody in 0.5% (w/v) gelatine in 1x PBS (Alexa Fluor 488 goat 185 
anti-mouse, Thermofisher) was then added and incubated for 60 min in the dark. The coverslip 186 
was placed on a microscope slide coated with mounting medium containing DAPI (Thermo). 187 
Slides were stored in the dark at 4°C and analysed using a laser scanning confocal microscope 188 




Generation of the conditional TbMCP17 double-knock out cell line 191 
The conditional double knock out of TbMCP17 was constructed using the target gene 192 
replacement method [39,49,50]. The cell line TbMCP17-cmycti was used as parental cell line 193 
for the generation of the conditional TbMCP17 double-knock out cell line. The 5’-UTR and 194 
3’-UTR of TbMCP17 were PCR amplified using the primer pairs 5’-195 
gctaGAGCTCcgtgtcgtgaggtggagaggtgatg-3’/5’-196 
gctaACTAGTcacacatcaccgcagccaagcaaaacaacg-3’ (5’-UTR 475 bp fragment), and 5’-197 
gcatGGATCCccgtgttcttgtttcaggtgtgaacc-3’/5’-ctatGGGCCCgtcaaacacattactggagcgg-3’ for 198 
the (3’-UTR 484 bp fragment). Using the underlined and capitalised restriction enzyme sites 199 
the amplified fragments were inserted on either side of the NEO (G418) (NEO-TbMCP17-200 
knock out vector) and BSD (blasticidin) (BSD-TbMCP17-knock out vector) antibiotic 201 
resistance cassettes, bearing actin 5'-splice sites and actin 3'-UTR [50]. After transfection of 202 
the TbMCP17-cmycti cell line with the NEO-TbMCP17-knock out construct and clonal 203 
selection with 15 µg/ml G418, the single-knock out cell line 204 
ΔTbMCP17::NEO/TbMCP17/TbMCP17-cmycti was obtained. The double knock out cell line 205 
ΔTbMCP17::NEO/ΔTbMCP17::BSD/TbMCP17-cmycti, (further referred to as 206 
ΔTbMCP17/TbMCP17-cmycti in this paper), was obtained after transfection of the 207 
ΔTbMCP17::NEO/TbMCP17/TbMCP17-cmycti cell line using the BSD-TbMCP17-knock out 208 
plasmid and clonal selection with 15 µg/ml G418 and 10 µg/ml blasticidin. The TbMCP17 209 
single- and double-knock out cell lines were cultured in the presence of tetracycline (1 µg/ml) 210 
to maintain TbMCP17-cmyc expression and ensure cell viability. The deletion of TbMCP17 211 
was confirmed by PCR analysis. 212 
 213 
Depletion of TbMCP17 by RNA interference 214 
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Inhibition of TbMCP17 expression was performed in PCF T. brucei using RNA interference 215 
(RNAi) [51]. The primer combinations 5’-gAAGCTTccaccccatttgatgttatcaagcagc-3’/5’-216 
ggCTCGAGtgactaagacatagcgcaccgcatcgg-3’ and 5’-cGGATCCccatttgatgttatcaagcagcggatg-217 
3’/5’-cAAGCTTtccCTCGAGcattgacagggcaccagcaggagcg-3’ were used to PCR amplify the 218 
387 bp sense and 467 bp antisense sequences of TbMCP17, respectively. The restriction 219 
enzyme sites used for subsequent cloning into the vector pHD676 are underlined and 220 
capitalised. The pHD676-TbMCP17 RNAi vector was used for transfection of procyclic form 221 
T. brucei PCF449. The TbMCP17RNAi cell line was obtained after clonal selection using 222 
hygromycin (25 µg/ml) and phleomycin (0.5 µg/ml).  223 
 224 
PCF T. brucei growth analysis 225 
For growth analysis, PCF cultures were diluted to a density of 5×105 cells/ml at the start of the 226 
experiments. During the growth experiments of the TbMCP17 overexpressing cells 227 
(TbMCP17-cmycti and TbMCP17-nmycti), 10 µg/ml tetracycline were added daily to maintain 228 
expression of the recombinant myc-tagged proteins. During the growth experiments of cells 229 
depleted of TbMCP17 by conditional knock out (ΔTbMCP17/TbMCP17-cmycti) tetracycline 230 
was removed from the cell culture 24 h prior the start of the growth experiments and cells were 231 
thoroughly washed using MEM-Pros to stop the expression of TbMCP17-cmyc. During the 232 
growth experiments of cells in which TbMCP17 was depleted by RNAi 10 µg/ml tetracycline 233 
were added daily to induce and maintain the RNA interference. Cell densities were determined 234 
every 24 h using a haemocytometer. In some experiments, the iron chelator deferoxamine 235 
(Sigma) was added at different concentrations (10 µM to 100 µM) to obtain iron deprived 236 
conditions. 237 
Western Blot 238 
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For each SDS-PAGE lane 5×106 cells were pelleted, resuspended in denaturing SDS-239 
containing Laemmli buffer, and heated at 95°C for 5 min. Proteins were separated on a 12% 240 
SDS-PAGE and then transferred to PVDF (GE Health Care Life Sciences) membranes at 100 241 
V for 50 min in Towbin buffer (48 mM Tris, 39 mM Glycine, 20% (v/v) methanol, pH 8.3). 242 
Membranes were blocked with 5% w/v skimmed milk in Tris-buffered saline buffer (TBS) 243 
and 0.1% Tween-20 (milk/TBST) at room temperature for 1 h. Subsequently, membranes were 244 
incubated with anti-c-myc (Roche) primary antibody diluted 1:2000 in milk/TBST, for 1 h at 245 
room temperature. Membranes were then washed 3 times with excess TBST and incubated 246 
with anti-mouse IgG HRP (Abcam) in secondary antibody diluted 1:2000 in milk/TBST, for 247 
1 h at room temperature. Protein detection was performed using an ECL detection kit 248 
(Amersham, GE Healthcare). Coomassie brilliant blue (CBB) staining was used as loading 249 
control. 250 
 251 
Iron measurement 252 
Cells were grown in iron and heme depleted medium to avoid interference during iron 253 
measurements. Depletion was achieved by pre-dialysing the foetal calf serum (FCS) using a 254 
Slide-A-Lyzer™ G2 dialysis cassette, 2K molecular weight cut-off, 70 mL (Thermo) 255 
according to manufacturer’s protocol. Briefly, heat-inactivated FCS was added to the dialysis 256 
cassette and put into 2 L of 1x PBS at 4°C for 3 h. After this time, the 1x PBS was discarded, 257 
replaced by fresh 1x PBS and dialysis was repeated 2 times more. Medium was then prepared 258 
using the dialysed FCS and without the addition of heme.  259 
Mitochondria of T. brucei were isolated by digitonin-fractionation according to previously 260 
published protocols [52]. Cellular and mitochondrial iron content were measured using a 261 
colorimetric ferrozine-based assay [53] with some modifications. Briefly, 100 µl aliquots of 262 
whole cell or mitochondrial lysates derived from 108 trypanosomes were placed in Eppendorf 263 
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tubes and mixed with 100 µl of 10 mM HCl, and 100 µl iron-releasing reagent (a freshly mixed 264 
solution of equal volumes of 1.4 M HCl and 4.5% (w/v) KMnO4). The mixture was then 265 
incubated for 2 h at 60 °C within a fume hood. After cooling to room temperature, 30 µl of the 266 
iron-detection reagent (6.5 mM ferrozine, 6.5 mM neocuproine, 2.5 M ammonium acetate, and 267 
1 M ascorbic acid) were added to each tube. After 30 min, the absorbtion  was measured at 268 
550 nm. The iron content of the sample was calculated by comparing its absorbtion to that of 269 
a range of equally treated iron (FeCl3) standards (0–300 µM). 270 
 271 
qRT PCR 272 
One-step real time qPCR was used to determine the expression levels of TbMCP17 after RNAi. 273 
Total RNA was isolated from 1×107 PCF T. brucei using TriFast (PeqLab Biotechnology 274 
GmbH) according to manufacturer ́s protocol. For cDNA synthesis 2 µg total RNA in 10 µl 275 
RNase-free water were mixed with 4 µl of 5× M-MuLV reaction buffer, 1 µl of RiboLock 276 
RNase inhibitor, 2 µl of 10 mM dNTP, and 2 µl of M-MuLV reverse transcriptase (cDNA 277 
synthesis kit, Thermo). The reaction was incubated at 25 °C for 5 min, followed by 60 min at 278 
37 °C. Then the reaction was terminated by incubation at 70 °C for 5 min. RT-PCR for the 279 
detection of TbMPC17 was performed using 1 µl of synthesised cDNA and the QuantiTect 280 
SYBR Green RT-PCR kit (QIAGEN) to set up a 25 µl PCR reaction. CT values of 281 
experimental samples (in triplicates) were compared with wild type CT after normalising CT 282 
from the house-keeping genes tubulin. 283 
 284 
TbMCP17 antibody generation 285 
His-tagged TbMCP17 was expressed in E. coli using the pET28a vector (Novagen). The 286 




gcttgcaGGATCCccgttcctccatgaacttcttggc-5’ and inserted into the vector using the restriction 289 
enzyme sites BamH I and Hind III (underlined). The Lemo21(DE3) E. coli strain was used for 290 
His-tagged TbMCP17 expression. Transformed cells were inoculated in LB media with 50 291 
µg/ml kanamycin and 30 µg/ml chloramphenicol and grown overnight. The next day the 292 
overnight culture was diluted 1/50 and protein expression was started at OD600 0.4-0.8 at 37 293 
°C by the addition of 0.4 mM IPTG for 4 h. 294 
Cells were harvested by centrifugation at 4,000×g for 10-20 min at 4 °C, resuspended in 5 295 
ml/g pellet native resuspension buffer (50 mM Na-phosphate pH 8.0, 300 mM NaCl, 296 
0.01%Tween-20) supplemented with protease inhibitor cocktail without EDTA (Sigma), 0.2 297 
mg/ml lysozyme and 5 unit/µl DNase. After incubation on ice for 30 min cells were passed 298 
through the French press until the lysate turned clear. TbMCP17 inclusion bodies were pelleted 299 
at 13,000×g for 30 min and solubilised using 5 M Urea or 1% sarcosyl. After solubilisation 300 
TbMCP17 was allowed to bind to 1 ml of Ni-NTA agarose (Qiagen)/20 ml of solubilised 301 
protein, and the mixture was stirred for 60 min at room temperature. The Ni-NTA agarose was 302 
washed according to the manufacturer´s protocol and TbMCP17 was eluted using 200 µl 303 
elution buffer (8 mM Na2HPO4, 286 mM NaCl, 1.4 mM KH2PO4, 2.6 mM KCl, 500 mM 304 
imidazole and 0.1% sarkosyl (w/v), pH 7.4). 3 mg of purified protein were loaded onto a 12 305 
% acrylamide prep-gel and dyed with Coomassie Brilliant Blue R-250. The protein band was 306 
cut out and sent to ThermoFisher Scientific for antibody generation. For western blot analysis 307 
the antiserum was diluted 1:250 in TBST containing 5% fish gelatine (Sigma) and detected 308 
using an anti-rabbit IgG HRP-conjugated secondary antibody (Abcam) diluted 1:2000 in 309 
gelatine/TBST. 310 





Sequence analyses suggest that TbMCP17 is a mitochondrial iron transporter 314 
Genome database searches using the amino acid sequences of the functionally characterised 315 
mitochondrial iron transporters from S. cerevisiae (MRS3 and MRS4) identified only one 316 
homologue in the genome of T. brucei, TbMCP17 (accession number Tb927.3.2980; [36]). 317 
Reciprocal BLASTP analysis of eukaryotic protein databases (http://www.ncbi.nlm.nih.gov) 318 
using the TbMCP17 amino acid sequence retrieved mitochondrial iron transporters from 319 
different species, including yeast MRS3 and MRS4, and mitoferrins from plants, mammals 320 
and insects. Syntenic homologues are also present in all other kinetoplastids and the free-living 321 
Bodo saltans; they include Leishmania major LmjF.29.2780 and Trypanosoma cruzi 322 
TcCLB.508153.630, and TcCLB.510315.20. 323 
The phylogenetic relationship of TbMCP17 with mitochondrial iron carriers of other 324 




Figure 1. TbMCP17 is evolutionarily related to mitochondrial iron transporters of the SLC25A 327 
family.  328 
The evolutionary relationship was analysed using a Neighbour-Joining tree. The bootstrap 329 
consensus tree was obtained after resampling analysis of 1,000 reiterated data sets. Only 330 
significant bootstrap values (≥ 50%) are shown. Branches corresponding to partitions 331 
reproduced in less than 50% bootstraps are collapsed. TbMCP17 is highlighted by bold face. 332 
Functionally characterised mitochondrial iron transporters are labelled with ‘*’. 333 
Corresponding accession numbers are indicated in the materials and methods section. 334 
 335 
TbMCP17 and homologous sequences from other trypanosomatids formed a well-defined, 336 
separate clade branching off near the iron carriers of plants with a well-resolved node and 337 
closely related to the mammalian mitoferrins and the iron carriers of insects. In mammals there 338 
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are two different isoforms of mitoferrins, MFRN1 and MFRN2 [31,54], forming two separate 339 
branches within the mammalian clade and supported by high bootstrap values (Figure 1). As 340 
expected, mitochondrial iron transporters from insects and mammals branched nearer to each 341 
other than to the iron carriers from plants and trypanosomatids (Figure 1). Rather surprisingly, 342 
instead of branching with the mammalian proteins, those from yeast formed an independent 343 
group that was not supported by high bootstrap values (Figure 1).  344 
The deduced amino acid sequence of TbMCP17 consists of 289 amino acid residues, which 345 
corresponds to a predicted molecular weight of 31.1 kDa (GeneDB). TbMCP17 contains three 346 
repetitive domains of about 100 amino acids, each harbouring two membrane-spanning alpha-347 
helices (Figure 2, H1-H6).  348 
 349 
 350 
Figure 2. TbMCP17 displays all conserved amino acid sequence features and functional 351 
residues present in mitochondrial iron carriers.  352 
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Sequence alignment of TbMCP17 with putative mitochondrial iron carrier sequences from 353 
Trypanosoma cruzi and Leishmania major, MRS3p and MRS4p Saccharomyces cerevisiae 354 
and mitoferrins from Drosophila melanogaster, Caenorhabditis elegans and Homo sapiens. 355 
The six transmembrane helices are indicated using a blue line (H1-6). The first and second 356 
part of the canonical signature sequence motifs are labelled with M1a, M2a and M3a, and 357 
M1b, M2b and M3b and are shaded in dark and light grey respectively. Substrate contact points 358 
are shaded in red (CPI), green (CPII) and blue (CPIII). The salt bridge networks are shaded in 359 
yellow. (*) indicate fully conserved residues, (:) indicate strongly conserved (scoring >0.5 in 360 
the Gonnet PAM 250 matrix), (.) indicate weakly conserved (scoring < 0.5 in the Gonnet PAM 361 
250 matrix). Corresponding accession numbers are indicated in the materials and methods 362 
section. 363 
 364 
Characteristic for MCF proteins is a bipartite signature motif: the first part of the signature 365 
motif (Px[D/E]x2[K/R]x[K/R], x represents any residue) (Figure 2, M1a, M2a, and M3a) is 366 
located at the carboxy-terminal end of the odd-numbered transmembrane helices, and the 367 
second part of the signature motif ([D/E]Gx4-5[W/F/Y][K/R]G) (Figure 2, M1b, M2b, and 368 
M3b) shortly before each even-numbered transmembrane helix, within an aliphatic loop [55–369 
57]. Multiple sequence alignments confirmed the conservation of the MCF-typical signature 370 
sequences (M1a/M2a/M3a) in TbMCP17 with some minor modifications (Figure 2). Within 371 
the first part of the signature sequence the proline at position one, the aspartic acid at position 372 
3 and the lysine at position 6 were conserved in TbMCP17 (Figure 2). The positively charged 373 
amino acid, either lysine or arginine, at position 8 was also conserved except in M3a (Figure 374 
2). The second part of the sequence signature (M1b/M2b/M3b) was less conserved except for 375 
the initial acidic residue (D or E) (Figure 2). In M1b the only substitution was at position 2 376 
where glycine was substituted for arginine. In M2b the last 2 amino acids of the motif ([K/R]G) 377 
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and the preceding aromatic amino acid [W/F/Y] were not conserved in TbMCP17. M3b was 378 
little conserved and retained only the final glycine (Figure 2). The other aligned sequences 379 
displayed similar levels of conservation in their signature motifs. 380 
In MCF proteins the substrate specificity is determined by three well-conserved substrate-381 
contact points (CPI, CPII and CPIII) (marked respectively red, green and blue in Figure 2) 382 
[35]. In TbMCP17, like in all iron carriers, the amino acids constituting CPI and CPII are 383 
[G/S]AY and MN respectively while CPIII is not conserved (Figure 2). Three further repetitive 384 
clusters of conserved residues ([FY][DE]XX[RK]) located in H2, H4 and H6 (marked yellow 385 
in Figure 2) are thought to be involved in the formation of salt bridge networks [58]. Except 386 
for the last amino acid in the motif located in H4 the other repetitive clusters are well conserved 387 
in all aligned sequences (Figure 2). 388 
 389 
TbMCP17 complements growth in ∆MRS3/4 yeast 390 
To assess the function of TbMCP17 as potential mitochondrial iron importer, functional 391 
complementation was performed in ∆MRS3/4 S. cerevisiae strains (GW403). The wild type 392 
and GW403 yeast strains were transfected using either empty pCM190 or pCM190 containing 393 
TbMCP17 or MRS3 and spotted on SCD (glucose) or SCG (glycerol) agar plates. The results 394 
showed that GW403 yeast transfected with empty pCM190 grew slower than wild type yeast 395 
or GW403 yeast complemented with either TbMCP17 or MRS3 (Figure 3A). This effect was 396 
particularly evident when the yeast was grown on glycerol instead of glucose as carbon source 397 





Figure 3. TbMCP17 complements the growth defect of the ∆MRS3/4 yeast cell line.  401 
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A. The yeast strain BY4741 (wild-type) was transfected with empty pCM190 vector and the 402 
yeast strain GW403 (ΔMRS3/4) was transfected with either empty pCM190 vector or with 403 
pCM190 vector containing either the TbMCP17 or the MRS3 ORF. Transfected yeast cells 404 
were spotted in ten-fold dilutions on plates containing synthetic complete media without uracil 405 
supplemented with either dextrose (SCD URA-) or glycerol (SCG URA-). B. and C. The yeast 406 
strain BY4741 (wild-type) was transfected with empty pCM190 vector and the yeast strain 407 
ΔMRS3/4 was transfected with either empty pCM190 vector or with pCM190 vector 408 
containing the TbMCP17 ORF. Transfected cells were grown either in standard YPD or YPG 409 
(B) or YPD or YPG supplemented with 80 µM bathophenanthrolinedisulfonic acid (BPS) (C). 410 
For each yeast strain three individual growth curves were plotted. Statistical significance was 411 
determined by one-way ANOVA using GraphPad Prism 7: *: p ≤ 0.05 **: p ≤ 0.01; ***p ≤ 412 
0.001. 413 
 414 
Next, the growth rates of the different yeast strains were analysed in YPD (glucose), YPG 415 
(glycerol), YPD/BPS (glucose and iron chelator) and YPG/BPS (glycerol and iron chelator) 416 
suspension culture media over a period of 32 h or 24 h (for experiments with BPS). The best 417 
growth rate for all tested yeast cell lines was observed on YPD medium. In this medium no 418 
difference in growth was observed between ∆MRS3/4 cells transfected with either TbMCP17 419 
or empty vector, which all grew slightly slower than the wild type strain (Figure 3B). In YPG 420 
media, the ∆MRS3/4 and the ∆MRS3/4 cell line transfected with empty vector grew 421 
significantly slower than wild type cells (Figure 3B). Transfection of the ∆MRS3/4 line with 422 
TbMCP17 partially rescued the growth to normal levels compared to the strain transfected 423 
with empty vector (Figure 3B). The addition of the iron chelator BPS resulted in drastically 424 
reduced growth rates for all strains on YPD and YPG medium compared with the growth 425 
without iron chelator (Figure 3C). However, in both media containing BPS, TbMCP17 426 
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improved the growth of the ∆MRS3/4 strain relatively to the strain transfected with empty 427 
vector (Figure 3C). Taken together these results demonstrated that TbMCP17 partially restores 428 
growth of the ∆MRS3/4 strain by complementing the transport function of the yeast iron 429 
carriers.  430 
 431 
TbMCP17 localises to the mitochondrion of PCF T. brucei 432 
Results from one of our previous publications demonstrated that the iron carrier, together with 433 
the dicarboxylate carrier TbMCP12, are the only T. brucei MCF carriers to be differentially 434 
expressed at the mRNA level [36,39]. Since those results showed that TbMCP17 is 435 
approximately 2-fold higher expressed in PCF than in BSF [36] and because we did not obtain 436 
viable BSF clones over expressing TbMCP17, in the current work we focussed on its 437 
functional characterisation in PCF only.  438 
Several attempts to detect endogenous TbMCP17 in PCF using the antibody we generated 439 
were not successful, although the antibody readily detected TbMCP17 in PCF when the protein 440 
was overexpressed (Supplementary Figure S1). When using our standard culturing conditions 441 




Supplementary Figure S1. Western blot analysis of TbMCP17 using the antibody we 444 
generated in wild type PCF and PCF overexpressing TbMCP17. In each lane 10 µl of sample 445 
containing 5x106 cells were loaded. 446 
 447 
Since the location of mitochondrial targeting sequences in proteins belonging to the SLC25A 448 
protein family has not been fully clarified yet [59–61] we assessed the subcellular localisation 449 
of TbMCP17 by over-expressing it bearing either a C-terminal or N-terminal myc-tag in PCF 450 
(MCP17-cmycti and MCP17-nmycti). In this way we ensure that the myc-tag is not interfering 451 
with the mitochondrial localisation of the protein.  Following transfection of PCF T. brucei 452 
with the over expression constructs, western blot analysis using an antibody directed against 453 
the myc-tag showed a band of approximately 33 kDa for both the TbMCP17-cmycti and the 454 
TbMCP17-nmycti PCF cell lines, but not for the wild type cells (Figure 4A). Leakiness of the 455 
tet-inducible expression-system in the absence of tetracycline [39,48] was not detectable by 456 
western blotting but cannot be excluded. Therefore wild-type cells were used as control cell-457 
line in all experiments. Immunofluorescence analysis using Mitotracker and an antibody 458 
directed against the myc-tag showed that both N- and C-terminally tagged TbMCP17 are 459 




Figure 4. In PCF TbMCP17 is localised in the mitochondrion and its overexpression confers 462 
increased resistance to iron depletion. 463 
A. Western blot analysis of WT PCF and PCF over-expressing TbMCP17 with either C-term 464 
(TbMCP17-cmycti) or N-term myc-tag (TbMCP17-nmycti). Coomassie brilliant blue (CBB) is 465 
used as loading control. B. Immunofluorescence analysis of PCF over expressing TbMCP17 466 
bearing either C-term (TbMCP17-cmycti) or N-term myc-tag (TbMCP17-nmycti). 467 
Mitochondria were visualised using Mitotracker (red) and TbMCP17-myc was detected using 468 
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a 1:1000 dilution of a myc antibody (green). Nucleus and kinetoplasts are stained with DAPI 469 
(blue). C. Growth analysis of PCF wild-type (WT), TbMCP17-cmycti and TbMCP17-nmycti 470 
cells in the absence and presence of the iron chelator deferoxamine. The growth experiment 471 
was started at a cell density of 0.5×106 cells/ml and cells were counted every 24 h for a period 472 
of 48 h. In some experiments, cells were treated with either 50 or 100 µM deferoxamine. For 473 
each cell-line three individual growth curves were plotted. Statistical significance was 474 
determined by one-way ANOVA using GraphPad Prism 7: *: p ≤ 0.05 **: p ≤ 0.01; ***p ≤ 475 
0.001. 476 
 477 
Over expression of TbMCP17 sustains growth under iron-limiting condition in PCF T. 478 
brucei 479 
To investigate whether a surplus of TbMCP17 enabled better survival of T. brucei under iron-480 
limiting conditions TbMCP17-cmycti and TbMCP17-nmycti procyclic cell lines were 481 
cultivated in medium containing different concentrations of the iron chelator deferoxamine. 482 
Deferoxamine is a conventionally used and well-established compound for blocking iron 483 
uptake in trypanosomes [62]. In contrast to BPS, it is membrane-permeable and chelates 484 
intracellular iron thereby blocking its incorporation into newly synthesized proteins [62]. In 485 
medium containing no deferoxamine, TbMCP17-cmycti and TbMCP17-nmycti cells doubled 486 
at the same speed as wild type cells (Figure 4C). The division time of wild type cells when 487 
exposed to 50 µM or 100 µM deferoxamine for 48 h was significantly slowed down compared 488 
to the cells overexpressing TbMCP17 (respectively p = 0.0012 and p = 0.0031) or untreated 489 
cells (respectively p = 0.0012 and p = 0.0042) (Figure 4C). Instead, the division time of 490 
TbMCP17-cmycti and TbMCP17-nmycti was not affected by the exposure to 50 µM iron 491 
chelator and only slightly but not significantly slowed down when exposed to 100 µM iron 492 
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chelator (Figure 4C). These results indicate that the overexpression of TbMCP17 confers 493 
increased resistance to iron depletion. 494 
 495 
TbMCP17 is required to sustain normal growth of PCF T. brucei 496 
We were next interested to investigate whether TbMCP17 was essential for procyclic T. brucei 497 
viability. To deplete TbMCP17 we used two different approaches: conditional gene knock out 498 
and RNA interference (RNAi).  499 
For the conditional gene knock out we replaced the two alleles of TbMCP17 with antibiotic 500 
resistant cassettes in the background of the tetracycline inducible TbMCP17-cmycti generating 501 
the cell-line DTbMCP17/TbMCP17-cmycti according to the previously published method [37–502 
39]. PCR using different primer sets located along the modified TbMCP17 gene locus 503 
(Supplementary Table 1) was performed to confirm the removal of the TbMCP17 gene and 504 
the correct insertion of the resistance cassettes (Supplementary Figure 2).  505 
 506 
Supplementary Table 1. Primers used for checking the correct integration of the knock out 507 
construct. 508 
 509 
Primer number Primer name Primer sequence 
427 MCP17upstreamFor  gatgatcgtatcggctcttgtcgcaatg 
339 MCP17KO5ForSac  gctagagctccgtgtcgtgaggtggagaggtgatg 
429 NEOFor  atgcggcggctggatacggttg 
82 BSDFor  atggccaagcctttgtctcaagaagaatccac 
83 BSDRev ttagccctcccacacataaccagagg 
105 NeoRev tcagaagaactcgtcaagaaggcgatagaag 
430 NeoRev2  cgagcccctgatgctcttcgtccagatcatcctgatc 
431 MCP17downstreamRev  aaggagtgggaacaggggcaaatccac 




Supplementary Figure 2. PCR analysis of the correct integration of the antibiotic resistance 511 
cassette in the DTbMCP17/TbMCP17-cmycti cell-line. A. gDNA derived from 512 
DTbMCP17/TbMCP17-cmycti was PCR amplified and loaded on a 0.5% agarose gel together 513 
with a DNA ladder. B. Schematic representation of the location of the primers used in A. 514 
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within the recombination site at the TbMCP17 gene locus. C. List of the primers used in A. 515 
and their predicted PCR amplified DNA fragment size.  516 
 517 
To check the correct integration of the antibiotic resistance cassettes, primers located upstream 518 
(427) and downstream (431) of the homologous recombination site were used in combination 519 
with primers located in the BSD (82 and 83) or NEO (105, 429, 430) ORFs (Supplementary 520 
Figure 2 C). All PCRs performed using genomic DNA derived from the TbMCP17 knock out 521 
cells produced a fragment of the predicted length confirming the integration of the resistance 522 
genes in the TbMCP17 locus  (Supplementary Figure 2 A and C). Tetracycline removal from 523 
the culture depletes the myc-tagged TbMCP17 (Figure 5A). This cell line was referred to as 524 




Figure 5. TbMCP17 depletion impairs PCF T. brucei growth and renders the cells more 527 
susceptible to iron depletion.  528 
A. Western blot analysis of TbMCP17 KO grown in the presence and absence of tetracycline 529 
for 48 h. Coomassie brilliant blue (CBB) is used as loading control. B. qPCR analysis of the 530 
TbMCP17 expression of 4 different TbMCP17 RNAi clones harvested after 48 h of growth in 531 
the presence of tetracycline. TbMCP17 expression of WT PCF was set to 1. Graph represents 532 
the mean of 3 independent experimental replicates and individual values are plotted. Statistical 533 
significance was determined by one-way ANOVA using GraphPad Prism 7: *: p ≤ 0.05 **: p 534 
≤ 0.01; ***p ≤ 0.001. C. and D. Growth analysis of PCF wild-type (WT) and TbMCP17 KO 535 
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(+ and – tet) PCF cells (C) or TbMCP17 RNAi PCF cells (D) in the absence or presence of the 536 
iron chelator deferoxamine. The analysis of the growth curve was started at a cell density of 537 
0.5x106 cells/ml and cells were counted every 24 h for a period of 48 h. In some experiments, 538 
cells were treated with either 50 or 100 µM deferoxamine. For each cell-line three individual 539 
growth curves were plotted. Statistical significance was determined by one-way ANOVA 540 
using GraphPad Prism 7: *: p ≤ 0.05 **: p ≤ 0.01; ***p ≤ 0.001. 541 
 542 
The efficacy of 4 TbMCP17 RNAi clones was tested using RT-qPCR. Compared to wildtype 543 
cells, in three clones we found over 100-fold reduction of the mRNA expression of TbMCP17 544 
(clones 1, 3 and 4), while in one (clone 2) only 4-fold reduction was achieved (Figure 5B).  545 
In medium containing no deferoxamine, the doubling time of the TbMCP17-cmycti depleted 546 
KO was significantly slowed down compared to either wild type or induced TbMCP17 KO 547 
(Figure 5C). A similar increase in doubling time compared to wild type cells was obtained 548 
when TbMCP17 was depleted by RNAi when no iron chelator was added to the culture  (Figure 549 
5D).  550 
The doubling time in iron-depleting conditions (50 or 100 µM deferoxamine) was significantly 551 
slowed down in the TbMCP17-cmycti depleted KO cells compared to wild type cells and 552 
induced TbMCP17 KO cells (Figure 5C). The TbMCP17-cmycti depleted KO, however, 553 
displayed a slight recovery after 48 h in culture. Like the TbMCP17-cmycti depleted KO, also 554 
the TbMCP17 RNAi cells displayed significantly increased sensitivity to iron depletion 555 
(Figure 5D) 556 
 557 
Mitochondrial iron content is decreased in TbMCP17 depleted cells 558 
We next measured the iron content of total cell lysates and isolated mitochondria in wild type, 559 
TbMCP17cmycti and TbMCP17 RNAi cell lines. In standard medium, wild type and 560 
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TbMCP17cmycti cells presented similar iron content in both whole cell lysates and 561 
mitochondria as well as comparable iron distribution percentage (Femito:Fetotal) (Figure 6A and 562 
C). TbMCP17 RNAi cell lines instead presented a slight, though not significant increment of 563 
the whole cell iron content compared to wild type and TbMCP17cmycti cells, while the 564 
mitochondrial iron content was unchanged. 565 
 566 
 567 
Figure 6. Mitochondrial iron content is reduced by the depletion of TbMCP17 only under iron 568 
limiting conditions.  569 
A. and B. The iron content was measured in whole cell extracts and isolated mitochondria 570 
derived from 1×108 WT, TbMCP17cmycti and TbMCP17 RNAi PCF cells, which were 571 
cultivated in normal (A) or heme-depleted medium (B). C. and D. Iron distribution 572 
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(Femito:Fetotal) in WT, TbMCP17cmycti and TbMCP17 RNAi PCF cells, which were cultivated 573 
in normal (C) or heme-depleted medium (D) medium. All graphs (A, B, C and D) were derived 574 
from 3, separately plotted, experiments. Statistical significance was determined by one-way 575 
ANOVA using GraphPad Prism 7: *: p ≤ 0.05 **: p ≤ 0.01; ***p ≤ 0.001. 576 
 577 
Trypanosomes are auxotrophic for heme [63,64]. After heme removal the iron content was 578 
significantly decreased only in isolated mitochondria of cells in which TbMCP17 was depleted 579 
(Figure 6B). The TbMCP17 RNAi cell-line also displayed a significantly lower iron 580 
distribution percentage compared with wild type cells and cells overexpressing 581 





The aim of this study was the identification of the carrier that is involved in the transport of 585 
iron across the inner mitochondrial membrane of the parasite T. brucei. Our results show that 586 
the T. brucei gene TbMCP17, which codes for a member of the SLC25A mitochondrial carrier 587 
family is the only homologue of mitochondrial iron transporters present in the genome of this 588 
parasite. Phylogenetic and amino acid sequence analysis demonstrated that TbMCP17 is 589 
closely related to the iron transporters of plants, insects and mammals and displays all 590 
signature motifs and residues typically found in mitochondrial iron carriers. It is interesting 591 
that as we previously reported for the mitochondrial dicarboxylate carrier TbMCP12 [39] also 592 
TbMCP17 appears to have a closer phylogenetic relationship to plant transporters than to those 593 
of Opisthokonts, although Excavata probably diverged equally early from both. Also, several 594 
T. brucei enzymes such as fructose-1,6-bisphosphate aldolase and arginine kinases were 595 
proposed to have arisen through horizontal gene transfer from either cyanobacteria, algae, 596 
plants or insects [39,65–68].  597 
TbMCP17 successfully rescued the growth defect of the ∆MRS3/4 (GW403) yeast strain on 598 
non-fermentable carbon sources. This observation strongly suggested that TbMCP17 can 599 
partially complement the function of yeast MRS3 and MRS4 on non-fermentable carbon 600 
sources by translocating iron into the mitochondrial matrix. Yeast growth was, however, never 601 
fully restored to wild type levels; perhaps amino acid sequence variations present in TbMCP17 602 
impair either its correct integration into the yeast mitochondrial inner membrane or the kinetics 603 
of the transport activity. Similar observations were already reported for the carrier TbMCP12 604 
[39]. 605 
In procyclic T. brucei, growth under iron limiting conditions was significantly improved when 606 
TbMCP17 was over-expressed, while down-regulation and knock out of TbMCP17 607 
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significantly reduced cell viability and caused hypersensitivity to iron deprivation. Similar 608 
susceptibility was previously observed when the mucolipin-like protein (TbMLP), an 609 
endosomal channel required for the assimilation of iron, was depleted from BSF T. brucei [14]. 610 
After 48 h of growth on deferoxamine we observed a partial recovery of the growth phenotype 611 
in the TbMCP17-cmycti depleted KO. Reasons for this observation might be: i) metabolic 612 
adjustments that compensate the decreased iron availability, ii) the upregulation of the 613 
expression of other mitochondrial carriers involved in iron transport eg. TbMCP23 or 614 
sideroflexins (TbSFNX). TbMCP23 is highly homologous to Rim2 [36], which mediates the 615 
translocation of iron and other divalent metal ions across the mitochondrial inner membrane. 616 
In yeast, the combined removal of Mrs3, Mrs4, and Rim2 caused a more severe Fe-S protein 617 
maturation defect than the depletion of the Mrs proteins alone [45]. Sideroflexins were 618 
identified in T. brucei and display high sequence similarity to the tricarboxylate transporter 619 
SLC25A1 (C. Colasante, unpublished data). The depletion of these proteins causes iron 620 
accumulation in mitochondria and siderocytic anaemia in mice [69,70], indicating their 621 
potential role in iron transport, iii) Selective pressure caused by the low iron concentration 622 
might exacerbate the leakiness of the tetracycline-inducible system generating sufficiently 623 
high amounts of TbMCP17 to improve growth though remaining under the detection limit of 624 
the western blot analysis. 625 
Our results suggested that iron storage is disturbed when TbMCP17 is absent and enhanced 626 
when its abundance is increased. When we analysed the iron content of total cell lysates of 627 
procyclic T. brucei we found, however, that the mitochondrial iron content and the 628 
Fe(mito)/Fe(total) ratio were significantly lowered in TbMCP17 RNAi cells under low iron 629 
conditions but never significantly elevated when TbMCP17 was overexpressed. This indicated 630 
that TbMCP17 downregulation decreased, as expected, mitochondrial iron import, which 631 
further substantiates its function as iron carrier. That TbMCP17 overexpression does not 632 
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increase mitochondrial iron storage in either normal or iron depleted conditions might be due 633 
to regulatory mechanisms that limit mitochondrial iron import. It was indeed previously shown 634 
that over expression of Mfrn1 and Mfrn2 did not increase mitochondrial iron depots in 635 
mammalian cells and that mitochondria modulate their own iron import [71,72]  636 
Several reports showed that in yeast the depletion of MRS3 and MRS4 did not change iron 637 
accumulation within mitochondria or the activity of the iron sulphur proteins aconitase and 638 
succinate dehydrogenase, except when the cells were deprived of iron [28,30]. The authors 639 
concluded that when iron is available other iron transport systems are supplying the 640 
mitochondrion and that MRS3 and MRS4 are only active when iron was low abundant [28,30]. 641 
In contrast, in mammalian cells, the knock out of Mrfn1 and Mrfn2 abolished mitochondrial 642 
iron import even when iron was provided to the medium[73]. Another study reported that the 643 
depletion of MRS3 and MRS4 induced the yeast iron regulon and led to an increased iron 644 
uptake into the cytoplasm and vacuole [73]. In rice shoots the depletion of the plant iron carrier 645 
MIT caused an elevation of intracellular, but a reduction of mitochondrial, iron content [74]. 646 
It appears that the regulation of the intracellular iron distribution in T. brucei is similar to that 647 
in yeast. Although, unlike yeast, T. brucei does not possess a vacuole, excess iron might be 648 
stored within a yet unidentified depot and released when cytosolic concentrations are below a 649 
certain threshold level [75]. It was previously suggested that this putative iron store could 650 
support the parasite´s growth for up to 48 h when iron is absent from the culture medium or 651 
when iron import to the cytoplasm is blocked [14,76,77]. 652 
Taken together with the phylogenetic and the sequence analysis, our results suggest that 653 
TbMCP17 acts as a mitochondrial iron carrier in T. brucei. We further propose that this carrier 654 
is particularly relevant for mitochondrial iron transport when iron is not readily available from 655 
the environment. 656 
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